Activation of P38 MAPK and NFκB protein by Western Blotting

ML Moonhee Lee
EM Edith G. McGeer
PM Patrick L. McGeer
request Request a Protocol
ask Ask a question
Favorite

Western blotting on cell lysates was performed as described previously [19]. Briefly, microglia and astrocytes were exposed to NaSH and STS at 100 μM for 8 h and were subsequently exposed to stimulants for 2 h. Human microglia and astrocytes were treated with a lysis buffer (150 mm NaCl, 12 mm deoxycholic acid, 0.1 % Nonidet P-40, 0.1 % Triton X-100, and 5 mm Tris-EDTA, pH 7.4). The protein concentration of the cell lysates was then determined using a BCA protein assay reagent kit (Pierce, Rockford, IL). Proteins in each sample were loaded onto gels and separated by 10 % sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (150 V, 1.5 h). The loading quantities of lysate proteins were 100 μg. Following SDS-PAGE, proteins were transferred to a PVDF membrane (Bio-Rad, CA) at 30 mA for 2 h. The membranes were blocked with 5 % milk in PBS-T (80 mm Na2HPO4, 20 mm NaH2PO4, 100 mm NaCl, 0.1 % Tween 20, pH 7.4) for 1 h and incubated overnight at 4 °C with a polyclonal anti-phospho-P38 MAP kinase antibody (9211, Cell Signaling, Beverly, MA, 1/2,000) or anti-phospho-P65 NFκB antibody (3031, Cell Signaling, 1/1,000). The membranes were then treated with a horseradish peroxidase-conjugated anti-IgG (P0448, DAKO, Mississauga, Ontario, CA, 1:2,000) or the secondary antibody anti-mouse IgG (A3682, Sigma, 1/3,000) for 3 h at room temperature, and the bands were visualized with an enhanced chemiluminescence system and exposure to photographic film (Hyperfilm ECL™, Amersham Biosciences). Equalization of protein loading was assessed independently using α-tubulin as the housekeeping protein. The primary antibody was anti-α-tubulin (T6074, Sigma, 1/2,000) and the secondary antibody anti-mouse IgG (A3682, Sigma, 1/3,000). Primary antibody incubation was overnight at 4 °C, and the secondary antibody incubation was for 3 h at room temperature.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A